Joint EANM/EANO/RANO practice guidelines/SNMMI procedure standards for imaging of gliomas using PET with radiolabelled amino acids and [18F]FDG: version 1.0

Law, I. (Ian); Albert, N. L. (Nathalie L.); Arbizu, J. (Javier); Boellaard, R. (Ronald); Drzezga, A. (Alexander); Galldiks, N. (Norbert); Fougère, C. (Christian) la; Langen, K. J (Karl-Josef); Lopci, E. (Egesta); Lowe, V. (Val); McConathy, J. (Jonathan); Quick, H. H. (Harald H.); Sattler, B. (Bernhard); Schuster, D. M. (David M.); Tonn, J. C (Jörg-Christian); Weller, M. (Michael)

Keywords:

Materias Investigacion::Ciencias de la Salud::Radiología
FDG
FET
MET
FDOPA
PET
Glioma

Issue Date:

2019

Publisher:

Springer Science and Business Media LLC

ISSN:

1619-7070

Note:

This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.

Citation:

Law, I. (Ian); Albert, N. L. (Nathalie L.); Arbizu, J. (J.); et al. "Joint EANM/EANO/RANO practice guidelines/SNMMI procedure standards for imaging of gliomas using PET with radiolabelled amino acids and [18F]FDG: version 1.0". European Journal of Nuclear Medicine and Molecular Imaging. (46), 2019, 540 - 557

Abstract

These joint practice guidelines, or procedure standards, were developed collaboratively by the European Association of Nuclear Medicine (EANM), the Society of Nuclear Medicine and Molecular Imaging (SNMMI), the European Association of Neurooncology (EANO), and the working group for Response Assessment in Neurooncology with PET (PET-RANO). Brain PET imaging is being increasingly used to supplement MRI in the clinical management of glioma. The aim of these standards/ guidelines is to assist nuclear medicine practitioners in recommending, performing, interpreting and reporting the results of brain PET imaging in patients with glioma to achieve a high-quality imaging standard for PET using FDG and the radiolabelled amino acids MET, FET and FDOPA. This will help promote the appropriate use of PET imaging and contribute to evidence-based medicine that may improve the diagnostic impact of this technique in neurooncological practice. The present document replaces a former version of the guidelines published in 2006 (Vander Borght et al. Eur J Nucl Med Mol Imaging. 33:1374–80, 2006), andsupplements a recent evidence-based recommendation by the PET-RANO working group and EANO on the clinical use of PET imaging in patients with glioma (Albert et al. Neuro Oncol. 18:1199–208, 2016). The information provided should be taken in the context of local conditions and regulations.

URI:

https://hdl.handle.net/10171/61571

DOI:

10.1007/s00259-018-4207-9

Appears in Collections:

DA - CUN - Medicina nuclear - Artículos de revista

Files in This Item: